LacZ Adeno-associated virus (AAV) serotype 2 is a widely used viral vector in genetic research and therapy. AAV is a small, non-enveloped virus belonging to the Parvoviridae family. AAV is replication-defective, does not cause inflammation, and does not cause human disease. Among the various serotypes, AAV2 has been the most extensively studied due to its versatility and ability to transduce a variety of cell types. AAV2 is able to stably deliver genes to ocular tissues such as the retina and uvea, and has low immunogenicity. Therefore, AAV2 is widely used in gene therapy for inherited retinal diseases, such as Leber hereditary retinopathy (LCA) and cone-cell atrophy.
The LacZ gene is often included in AAV2 vectors as a reporter gene. LacZ encodes the enzyme β-galactosidase, which hydrolyzes lactose into glucose and galactose. Researchers use LacZ as a marker to track gene expression, vector distribution, and successful transduction in host cells. The presence of LacZ enables scientists to histochemically stain cells and tissues with X-gal, a substrate that turns blue upon enzymatic cleavage, thereby visualizing the extent and location of gene expression.
Transplantation of cells into the infarcted heart has the potential to improve myocardial recovery significantly. However, the low efficiency of cell implantation still limits the therapeutic efficacy. Here, researchers report the results of competitive screening of most known chemokines and interleukins to assess their ability to promote cardiac engraftment of bone marrow (BM)-derived MSCs and to rank their relative efficacy. This competitive implant screen was performed by adapting the in vivo functional selection (FunSel) method. FunSel is based on the use of a panel of secreted factors, each encoded by a different adeno-associated virus (AAV) vector. Here, mixed preparations of these vectors were used to transduce MSCs in vitro and then transplant them into the heart under normal and ischemic conditions. By ranking 80 different cytokines and growth factors for their ability to stimulate heart engraftment by mesenchymal stromal cells, cardiotrophin-1 (Ctf1) was found to be the most potent factor in both normal and infarcted hearts. Enhanced engraftment of Ctf1-preconditioned mesenchymal stromal cells was mediated by the rapid activation of the focal adhesion complexes of the cells.
Proper adhesion to the extracellular matrix is known to be a major determinant of cell survival in many experimental settings and appears to be particularly important following cell transplantation in environments of hypoxia and high oxidative stress levels, such as the infarcted myocardium. Indeed, the researchers found that Ctf1 protected BM-MSCs from oxidative damage. Cells were treated with hydrogen peroxide after transduction with AAV2-Ctf1 or pretreated with rCtf1. In both cases, the number of apoptotic cells (quantified by terminal deoxynucleotidyl transferase dUTP nick end labeling positivity) was reduced by more than 2.5-fold compared to the corresponding controls (transduction with AAV2-LacZ or untreated cells, respectively; Figures 1A and 1B are representative images and quantification, respectively). Caspase 3/7 activation was also measured in cells treated with rCtf1 and this apoptotic marker was similarly reduced (Figure 1C).
Figure 1. Cardiotrophin-1 (Ctf1) protects bone marrow–derived mesenchymal stromal cells (BM-MSCs) from apoptosis. (Bortolotti F, et al., 2017)
Customer Reviews
Outstanding product
I’ve been using the LacZ AAV Serotype 2 for my gene delivery studies, and the results have been outstanding.
Write a Review